[go: up one dir, main page]

NO20091236L - Salter av benzimidazolyl pyridylestere og formuleringer av disse - Google Patents

Salter av benzimidazolyl pyridylestere og formuleringer av disse

Info

Publication number
NO20091236L
NO20091236L NO20091236A NO20091236A NO20091236L NO 20091236 L NO20091236 L NO 20091236L NO 20091236 A NO20091236 A NO 20091236A NO 20091236 A NO20091236 A NO 20091236A NO 20091236 L NO20091236 L NO 20091236L
Authority
NO
Norway
Prior art keywords
salts
formulations
benzimidazolyl pyridyl
pyridyl esters
esters
Prior art date
Application number
NO20091236A
Other languages
English (en)
Inventor
Rampurna Gullapalli
Ahmad Hashash
Piotr H Karpinski
Kangwen L Lin
Eric M Loeser
Augustus O Okhamafe
Paul Allen Sutton
Eduardo Sy
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20091236L publication Critical patent/NO20091236L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Salter av benzimidazolylpyridyletere er tilveiebragt, særlig salter av {1-metyl-5-[2-(5-trifluormetyl-1H-imidazol-2-yl)-pyridin-4-yloksy]-1H-benzimidazol-2-yl}-(4-trifluormetyl-fenyl)amin. Sammensetninger og formuleringer som inkluderer slike salter og surfaktanter så vel som fremgangsmåter for fremstilling av slike sammensetninger og formuleringer er tilveiebragt.
NO20091236A 2006-08-30 2009-03-24 Salter av benzimidazolyl pyridylestere og formuleringer av disse NO20091236L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84117706P 2006-08-30 2006-08-30
US95446607P 2007-08-07 2007-08-07
PCT/US2007/019152 WO2008027523A2 (en) 2006-08-30 2007-08-30 Salts of benzimidazolyl pyridyl ethers and formulations thereof

Publications (1)

Publication Number Publication Date
NO20091236L true NO20091236L (no) 2009-03-27

Family

ID=39027583

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091236A NO20091236L (no) 2006-08-30 2009-03-24 Salter av benzimidazolyl pyridylestere og formuleringer av disse

Country Status (33)

Country Link
US (2) US8202998B2 (no)
EP (1) EP2059518B1 (no)
JP (1) JP5279712B2 (no)
KR (1) KR20090043542A (no)
CN (1) CN101516870B (no)
AT (1) ATE504584T1 (no)
AU (1) AU2007290388B2 (no)
BR (1) BRPI0716243A2 (no)
CA (1) CA2660376C (no)
CL (1) CL2007002533A1 (no)
CO (1) CO6150180A2 (no)
CY (1) CY1112187T1 (no)
DE (1) DE602007013774D1 (no)
DK (1) DK2059518T3 (no)
ES (1) ES2360968T3 (no)
GT (1) GT200900045A (no)
HR (1) HRP20110311T1 (no)
IL (1) IL196811A (no)
JO (1) JO2702B1 (no)
MA (1) MA30711B1 (no)
MX (1) MX2009002279A (no)
MY (1) MY161829A (no)
NO (1) NO20091236L (no)
NZ (1) NZ574620A (no)
PE (2) PE20080766A1 (no)
PL (1) PL2059518T3 (no)
PT (1) PT2059518E (no)
RU (1) RU2457206C2 (no)
SI (1) SI2059518T1 (no)
TN (1) TN2009000068A1 (no)
TW (1) TW200819438A (no)
WO (1) WO2008027523A2 (no)
ZA (1) ZA200900664B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080766A1 (es) * 2006-08-30 2008-06-15 Novartis Ag Sales de benzimidazolil piridil eteres y formulaciones que las contienen
WO2008140850A1 (en) * 2007-03-02 2008-11-20 Novartis Ag Solid forms of a raf kinase inhibitor
AU2009257487B2 (en) * 2008-06-13 2013-01-31 Novartis Ag Substituted benzimidazoles for neurofibromatosis
DK2391366T3 (da) * 2009-01-29 2013-01-07 Novartis Ag Substituerede benzimidazoler til behandling af astrocytomer
WO2011044072A1 (en) 2009-10-05 2011-04-14 Novartis Ag Combination of raf-265 and an activator of ampk for use in the treatment of a proliferative disease
PH12013501098A1 (en) * 2010-12-03 2013-07-08 Novartis Ag Pharmaceutical compositions
WO2021110697A1 (en) * 2019-12-02 2021-06-10 Astrazeneca Ab Solid pharmaceutical formulations of 6-(2-chloro-6-methylpyridin-4-yl)-5-(-4-fluorophenyl)-1,2,4-triazin-3-amine
CN114478519B (zh) * 2020-10-23 2024-06-11 励缔(杭州)医药科技有限公司 吡唑并吡啶类化合物或其盐及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299108B2 (en) * 2002-03-29 2012-10-30 Novartis Ag Substituted benzazoles and methods of their use as inhibitors of raf kinase
JP4628678B2 (ja) 2002-03-29 2011-02-09 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 置換ベンズアゾールおよびＲａｆキナーゼ阻害剤としてのそれらの使用
US20060189619A1 (en) 2005-02-24 2006-08-24 Wyeth 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds
PE20070427A1 (es) * 2005-08-30 2007-04-21 Novartis Ag Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas
US7731795B2 (en) 2005-12-02 2010-06-08 Clemson University Rhombohedral fluoroberyllium borate crystals and hydrothermal growth thereof for use in laser and non-linear optical applications and devices
DK2046292T3 (da) * 2006-07-21 2010-06-07 Novartis Ag Formuleringer for benzimidazolylpyridylethere
PE20080766A1 (es) * 2006-08-30 2008-06-15 Novartis Ag Sales de benzimidazolil piridil eteres y formulaciones que las contienen

Also Published As

Publication number Publication date
US20120308651A1 (en) 2012-12-06
EP2059518A2 (en) 2009-05-20
DK2059518T3 (da) 2011-05-16
JP2010502622A (ja) 2010-01-28
US20100168060A1 (en) 2010-07-01
CN101516870B (zh) 2013-09-11
HRP20110311T1 (hr) 2011-08-31
HK1131613A1 (en) 2010-01-29
CO6150180A2 (es) 2010-04-20
ES2360968T3 (es) 2011-06-10
MY161829A (en) 2017-05-15
BRPI0716243A2 (pt) 2013-09-03
US8202998B2 (en) 2012-06-19
IL196811A (en) 2013-03-24
ATE504584T1 (de) 2011-04-15
AU2007290388A1 (en) 2008-03-06
CA2660376A1 (en) 2008-03-06
AU2007290388B2 (en) 2011-07-14
MA30711B1 (fr) 2009-09-01
ZA200900664B (en) 2009-12-30
CY1112187T1 (el) 2015-12-09
IL196811A0 (en) 2009-11-18
MX2009002279A (es) 2009-03-20
DE602007013774D1 (de) 2011-05-19
PE20130814A1 (es) 2013-08-08
PE20080766A1 (es) 2008-06-15
SI2059518T1 (sl) 2011-06-30
NZ574620A (en) 2011-05-27
TW200819438A (en) 2008-05-01
RU2009111384A (ru) 2010-10-10
PL2059518T3 (pl) 2011-09-30
RU2457206C2 (ru) 2012-07-27
GT200900045A (es) 2010-06-14
CA2660376C (en) 2014-04-15
TN2009000068A1 (en) 2010-08-19
CL2007002533A1 (es) 2008-02-08
WO2008027523A3 (en) 2008-04-10
JO2702B1 (en) 2013-03-03
KR20090043542A (ko) 2009-05-06
PT2059518E (pt) 2011-07-11
WO2008027523A2 (en) 2008-03-06
CN101516870A (zh) 2009-08-26
US8501785B2 (en) 2013-08-06
JP5279712B2 (ja) 2013-09-04
EP2059518B1 (en) 2011-04-06

Similar Documents

Publication Publication Date Title
NO20091236L (no) Salter av benzimidazolyl pyridylestere og formuleringer av disse
NO20090738L (no) Tilveiebringelse av EP2 agonister, fremgangsmate for fremstilling derav, farmasoytiske sammensetninger inneholdende disse forbindelser og fremgangsmater for anvendelse av forbindelsene og sammensetningene for a senke intraokkulaert trykk og behandle glaukom
UA102534C2 (xx) ТВЕРДА ФОРМА 3-(6-(1-(2,2-ДИФТОРБЕНЗО$d]$1,3]-ДІОКСОЛ-5-ІЛ)-ЦИКЛОПРОПАНКАРБОКСАМІДО)-3-МЕТИЛПІРИДИН-2-ІЛ)БЕНЗОЙНОЇ КИСЛОТИ (ВАРІАНТИ)$ТВЕРДАЯ ФОРМА 3-(6-(1-(2,2-ДИФТОРБЕНЗО$d]$1,3]-ДИОКСОЛ-5-ИЛ)-ЦИКЛОПРОПАНКАРБОКСАМИДО)-3-МЕТИЛПИРИДИН-2-ИЛ)БЕНЗОЙНОЙ КИСЛОТЫ (ВАРИАНТЫ)
NO20084924L (no) N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer
NZ600801A (en) Substituted imidazopyridinyl-aminopyridine compounds
EA200800549A1 (ru) Региоселективный способ получения бензимидазолтиофенов
EP2023926A4 (en) PYRIDONECARBOXAMIDE DERIVATIVES USEFUL FOR TREATING HYPERPROLIFERATIVE AND ANGIOGENESIS RELATED DISORDERS
AU2009215514A9 (en) Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
NO20075918L (no) Substituerte pyrrolo-pyridiner, forbindelser inneholdende disse, fremgangsmate for deres fremstilling og anvendelse derav
NO20081160L (no) Benzimidazoltiofen forbindelser
NO20075275L (no) Nye forbindelser
DK2107055T3 (da) Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1994005T3 (da) Tetrahydronaphthalinderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelseshæmmere
NO20084543L (no) Benzimidazolderivater
DK2114884T3 (da) Fremgangsmåde til fremstilling af 2-substituerede 5-(1-alkylthio)alkylpyridiner
IL189961A0 (en) Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors
NO20082589L (no) Nye indolizinderivater, fremgangsmate for fremstilling av samme og terapeutiske sammensetninger som inbefatter samme
FR2905620B1 (fr) Machine-outil notamment de percage-rivetage et ses procedes de travail
NO20092719L (no) Nye kromen-2-on-derivater og deres anvendelse som monoaminneurotransmitter-gjenopptaksinhibitorer
NO20070329L (no) Nye alkylsubstituerte piperazinderivater og deres anvendelse som monoaminneurotransmittergjenopptaksinhibitorer
CR8955A (es) Hexadecasacaridos biotinilados, su preparacion y su utilizacion
AR062591A1 (es) Sales de benzimidazolil piridil eteres y formulaciones que las contienen
ATE528384T1 (de) Zusammensetzung und verfahren
UA92180C2 (en) Benzimidazole thiophene compounds as plk inhibitors
TN2011000588A1 (en) Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl) pyridine and their therapeutical uses

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application